Skip to main content
. 2016 Feb 11;2016(2):CD003428. doi: 10.1002/14651858.CD003428.pub3
Date Event Description
11 February 2016 Amended The review has been split into two reviews, one looking at short‐acting inhaled bronchodilators for people with cystic fibrosis and one looking at long‐acting inhaled bronchodilators in this population. This version will remain withdrawn when the new reviews are published.